Articles: sars-cov-2.
-
The aim of this study was to analyse the group of newborns who were admitted at Neonatal Department of Intensive Medicine in Bratislava Faculty of Medicine Comenius University in Bratislava and National Institute of Children´s Diseases in the period from 08.01.2021 until 07.07.2023 who were affected by the COVID-19 virus from mother before birth, from staff or in family or were only in contact with COVID-19 positive person. ⋯ COVID-19 pandemic had a great impact on the pregnant women as well as on prenatal and postnatal development of the child. Our results reveal that the severity of symptoms in COVID-19 infected newborns from our sample was low. It is important to implement adequate neonatal practices for early detection of illnesses, especially in relation to COVID-19 which will subsequently allow early intervention and reduce neonatal mortality. Future challenges for all countries include the implementation of higher hygiene standards, prevention of spreading, more sensitive tests to use in the first day of life (Tab. 3, Ref. 36).
-
Eur. J. Intern. Med. · Jan 2024
Global burden of new-onset hypertension associated with severe acute respiratory syndrome coronavirus 2 infection.
Several reports documented a specific effect of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on blood pressure (BP), during and after the acute phase of infection. Clinical studies demonstrated that coronavirus disease 2019 (COVID-19) is associated with an increased risk of a persistent increase in BP requiring a new or intensified anti-hypertensive treatment during hospitalization. The picture is further complicated by the evidence from large databases showing an increased risk of new-onset hypertension in COVID-19 survivors on the long term. ⋯ In both the acute phase and recovery from infection, the interaction between spike proteins of SARS-CoV-2 and angiotensin converting enzyme 2 (ACE2) receptors remain the most plausible mechanism explaining the raise in BP (ranking new onset hypertension as one of the most prevalent cardiovascular sequelae of COVID-19). In this area of research, it is worth to mention that new variants of SARS-CoV-2 exhibit specific mutations in the spike protein that promotes entry into viral cells via ACE2. Thus, the enhanced spike affinity for ACE2 of new variants has the potential to increase the risk of new-onset hypertension when compared with the original Wuhan strain.
-
Since the onset of the COVID-19 pandemic, cases of COVID-19-associated pulmonary aspergillosis (CAPA) have been described. Possible risk factors for the development of this condition have been proposed, although evidence in Latin American populations is limited. The objectives were to identify risk factors for the development of CAPA and describe the characteristics of this infection. ⋯ A history of diabetes, smoking, coronary artery disease, and a Charlson score equal to or greater than 5 may increase the risk of developing CAPA.
-
Rev Assoc Med Bras (1992) · Jan 2024
Observational StudyProlonged urinary retention in COVID-19 survivors: observational study.
Initially diagnosed as a respiratory disease, SARS-CoV-2 revealed numerous extrapulmonary implications. The aim of this study was to investigate prolonged urinary retention in survivors post-COVID-19 infection that led to hospitalization. ⋯ Urinary tract involvement in COVID-19 infection is increasingly evident. The correlation between COVID-19 severity and failure to remove the urinary catheter in a similar percentage of men and women reinforces the hypothesis that sex-independent urothelial injury and bladder dysfunction might be caused by COVID-19.